Skip to content

Modified New Staging System for Gastric-type Endocervical Adenocarcinoma: A Multicenter, Retrospective Study

Modified New Staging System for Gastric-type Endocervical Adenocarcinoma: A Multicenter, Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105891
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric-type endocervical adenocarcinoma(G-EAC)

Interventions

Sponsors

Obstetris & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with G-EAC who underwent primary surgical treatment or surgery after neoadjuvant therapy; 2.Patients with unexpectedly diagnosed G-EAC on postoperative histopathology after hysterectomy; 3.G-EAC patients who received chemoradiotherapy alone without surgery; 4.Patients with comprehensively documented clinical and pathological records;

Exclusion criteria

Exclusion criteria: 1.Patients with concurrent primary malignancies of other types, including gynecological malignancies of non-G-EAC origin; 2.Patients diagnosed with G-EAC during pregnancy; 3.Octogenarian and older G-EAC patients (age >80); 4.Patients with postoperative follow-up <12 months or lost to follow-up;

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival (PFS);Overall Survival(OS);

Countries

China

Contacts

Public ContactJingxin Ding

Obstetris & Gynecology Hospital of Fudan University

djxdd@sina.com+86 2100000000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026